Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dharmesh Kapoor

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The Journal of the Association of Physicians of India|September 2, 2021
Primary Prophylaxis Patterns for Hepatic Encephalopathy in Patients with Liver Cirrhosis: What are the Current Prescribing Trends in Specialty Practice?B D Goswami, Dharmesh Kapoor, Sandeep Nijhawan, et al.
Journal of Clinical and Experimental Hepatology|October 8, 2020
Living Donor Liver Transplantation in a Paediatric Patient With Citrullinaemia Type 2Rajiv Maharaj, Venugopal Kota, Balbir Singh, et al.
Open Forum Infectious Diseases|April 6, 2019
Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV ClassificationCharlotte Hedskog, Bandita Parhy, Silvia Chang, et al.
Hepatology International|February 22, 2019
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in IndiaAjit Sood, Ajay Duseja, Mayank Kabrawala, et al.
Journal of Clinical and Experimental Hepatology|May 11, 2018
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman StatementsAnil Arora, Shivaram P Singh, Ashish Kumar, et al.
Journal of Clinical and Experimental Hepatology|December 3, 2015
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology|August 6, 2016
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Journal of Clinical and Experimental Hepatology|October 13, 2017
Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|November 16, 2016
Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypesSamir R Shah, P N Rao, Shiv K Sarin, et al.
Journal of Clinical and Experimental Hepatology|May 9, 2025
Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver TransplantationAnil Arora, Praveen Sharma, Ashish Kumar, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The Journal of the Association of Physicians of India|September 2, 2021
Primary Prophylaxis Patterns for Hepatic Encephalopathy in Patients with Liver Cirrhosis: What are the Current Prescribing Trends in Specialty Practice?B D Goswami, Dharmesh Kapoor, Sandeep Nijhawan, et al.
Journal of Clinical and Experimental Hepatology|October 8, 2020
Living Donor Liver Transplantation in a Paediatric Patient With Citrullinaemia Type 2Rajiv Maharaj, Venugopal Kota, Balbir Singh, et al.
Open Forum Infectious Diseases|April 6, 2019
Identification of 19 Novel Hepatitis C Virus Subtypes-Further Expanding HCV ClassificationCharlotte Hedskog, Bandita Parhy, Silvia Chang, et al.
Hepatology International|February 22, 2019
Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in IndiaAjit Sood, Ajay Duseja, Mayank Kabrawala, et al.
Journal of Clinical and Experimental Hepatology|May 11, 2018
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman StatementsAnil Arora, Shivaram P Singh, Ashish Kumar, et al.
Journal of Clinical and Experimental Hepatology|December 3, 2015
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
Journal of Clinical and Experimental Hepatology|August 6, 2016
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Journal of Clinical and Experimental Hepatology|October 13, 2017
Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|November 16, 2016
Chronic hepatitis C virus infection in India: Regional demographics and distribution of viral genotypesSamir R Shah, P N Rao, Shiv K Sarin, et al.
Journal of Clinical and Experimental Hepatology|May 9, 2025
Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver TransplantationAnil Arora, Praveen Sharma, Ashish Kumar, et al.
Pageof 5